Why Oracle's AI Spending Spree Is Spooking Wall Street

Oracle Corp. (NYSE: ORCL) faces scrutiny for aggressive AI push. Q2 results disappoint, stock price drops. TikTok deal adds uncertainty.

Insider Decision: Clayton M Magouyrk Offloads $1.93M Worth Of Oracle Stock

What Happened: Magouyrk's decision to sell 10,000 shares of Oracle was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday. The total value of the sale is ...

I'm Buying What Oracle Is Building

Oracle (ORCL) is a top AI infrastructure stock with booming cloud revenue, major partnerships, and strong growth—see why it’s ...
Becker's Hospital Review

Senators raise concerns over VA Oracle Health EHR rollout

Three U.S. senators have penned a letter to the U.S. Department of Veterans Affairs expressing apprehensions over the resumption of the agency’s EHR rollout in 2026. The project has been on hold amid ...

Driving Efficiency in Pharma: The 40% Cloud Cost Breakthrough

Nivedha Sampath’s platform engineering and cloud governance initiatives showcase how regulated pharmaceutical environments can be modernized to improve efficiency and control infrastructure spend.